Baird Medical Investment ... (BDMD)
5.40
-0.11 (-2.00%)
At close: Mar 31, 2025, 12:12 PM
Company Description
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China.
The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps.
Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Baird Medical Investment Limited
| Country | CN |
| IPO Date | Dec 16, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 148 |
| CEO | Haimei Wu |
Contact Details
Address: Room 202 Guangzhou, CN | |
| Website | https://www.bairdmed.com |
Stock Details
| Ticker Symbol | BDMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001982444 |
| CUSIP Number | G0705H103 |
| ISIN Number | KYG0705H1039 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Haimei Wu | Chairwoman of the Board of Directors & Chief Executive Officer |
| Jie Li | Acting Chief Financial Officer |
| Rongjian Lu | Chief Technology Officer & Deputy GM |
| Quan Qiu | Chief Administrative Officer & Executive Director |
| Wei Hou | Executive Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 28, 2025 | 6-K | Filing |
| Jan 17, 2025 | F-1/A | [Amend] Filing |
| Jan 10, 2025 | S-8 | Filing |
| Nov 15, 2024 | F-1 | Filing |
| Nov 01, 2024 | 6-K | Filing |
| Oct 09, 2024 | 20FR12B | Filing |
| Oct 02, 2024 | CERT | Filing |
| Oct 02, 2024 | 6-K | Filing |
| Oct 01, 2024 | 8-A12B | Filing |
| Sep 06, 2024 | 425 | Filing |